Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors [Phase 2]
Phase 2 clinical trial of TJ004309 in combination with atezolizumab (TECENTRIQ) for ovarian cancer and selected solid tumors has completed e…
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: Tarlox and Sotorasib in Patients With KRAS G12C Mutations [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating Tarlox and sotorasib in KRAS G12C-mutant non-small cell lung cancer has been terminated with results pos…
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: Clinical Study of the Therapeutic Effectiveness of In-silico-Designed, Machine Learning Inspired, and Quantum-molecularly Coupled Personalized Neoantigenic Vaccines Microlyvaq™ in Patients With Advanced Non-small Cell Lung Cancer [EARLY_Phase 1]
Early Phase 1 update on Microlyvaq™, a personalized neoantigenic vaccine designed with in-silico, machine-learning, and quantum-molecular co…
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: Durvalumab and Chemotherapy Induction Followed by Durvalumab and Radiotherapy in Large Volume Stage III NSCLC [Phase 2]
Phase 2 trial evaluating induction chemotherapy with durvalumab followed by durvalumab with radiotherapy in large-volume stage III non-small…
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 study of the antibody-drug conjugate MYTX-011 in non-small cell lung cancer has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: A Study to Evaluate ANS014004 in Combination With EGFR-TKI in Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating ANS014004 in combination with an EGFR-TKI for Non-Small Cell Lung Cancer with EGFR mutations. The stud…
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: A Study of SGN-B6A in Chinese Participants With Advanced Solid Tumors [Phase 1]
A Phase 1 study of SGN-B6A in Chinese participants with advanced solid tumors has completed, reporting safety and preliminary activity acros…
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: Nivolumab for the Reversal of Squamous Dysplasia in High Risk Current and Former Smokers [Phase 2]
Phase 2 trial evaluating nivolumab for reversal of squamous dysplasia in high-risk current and former smokers; results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer) [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial by Hoffmann-La Roche evaluating multiple immunotherapy-based treatment combinations in metastatic non-s…
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors [Phase 3]
Phase 3 trial evaluating the duration of PD-1/PD-L1 inhibitor therapy in advanced solid tumors; the study has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: MAGE A10ᶜ⁷⁹⁶T for Advanced NSCLC [Phase 1]
A Phase 1 trial of Adaptimmune's MAGE-A10 796T T-cell receptor therapy for advanced non-small cell lung cancer has completed the Phase 1 sta…
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: An Autologous NK/CIK Cell Product (PB101) in Combination With EGFR-TKI for Treating Lung Cancer [Phase 1]
Phase 1 trial update of PB101, an autologous NK/CIK cell product, in combination with an EGFR-TKI, for non-small cell lung cancer; the study…
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: Evaluation of Efficacy of Minimally Invasive Local Therapy for Lung Tumors and Its Impact on Breathing Function [NA]
Clinical trial update on evaluating the efficacy of minimally invasive local therapy for lung tumors and its impact on breathing function.
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) [Phase 2]
Phase 2 trial update for sotorasib (AMG 510) in KRAS G12C-mutated advanced non-squamous non-small cell lung cancer, highlighting ongoing stu…
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Cancer Therapy-Related Cardiac Dysfunction Associated With EGFR-TKIs in Advanced EGFR-mutant Non-small Cell Lung Cancer
A completed clinical trial update investigates cancer therapy-related cardiac dysfunction associated with EGFR-TKIs in advanced EGFR-mutant …
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer [Phase 2]
A Phase 2 trial evaluating Vidutolimod in combination with cemiplimab for adults with advanced or metastatic cancers was terminated, with re…
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC [Phase 1]
Phase 1 study evaluating the safety and feasibility of combining pirfenidone with standard first-line chemotherapy in advanced non-small cel…
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Staggered, Chemo-Immunotherapy With Durvalumab, MEDI4736 Pemetrexed & Carboplatin (PC) for Metastatic Non-Squamous NSCLC [Phase 2]
Phase 2 trial evaluating staggered durvalumab with pemetrexed and carboplatin for metastatic non-squamous non-small cell lung cancer; the st…
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion [Phase 1]
Bristol-Myers Squibb is conducting a Phase 1 trial of MRTX1719 in MTAP-deleted solid tumors, including mesothelioma, non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Atezolizumab Plus Bevacizumab in First Line NSCLC Patients [Phase 2]
This update reports results from a Phase 2 trial evaluating the combination of Atezolizumab and Bevacizumab as first-line therapy for Non-Sm…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer [Phase 1, Phase 2]
Takeda's TAK-186 (MVC-101) was studied in a Phase 1/2 trial for adults with advanced or metastatic cancers including squamous cell carcinoma…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Early Assessment of Response to Treatment of Metastatic LUng Tumors Based on CIrculating Tumor DNA [NA]
A completed clinical trial update evaluating early response to treatment in metastatic non-small cell lung cancer using circulating tumor DN…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1) [Phase 1, Phase 2]
A Phase 1/2 clinical trial update on sunvozertinib, an oral EGFR inhibitor, in adults with advanced non-small cell lung cancer harboring EGF…
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Palliative RadIotherapy of Multiple Metastatic Sites Before First Line of Systemic Therapy With Immune Checkpoint Inhibitors and Chemotherapy in Metastatic Non-Small-Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating palliative radiotherapy to multiple metastatic sites before first-line systemic therapy with immune checkpoint in…
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Real-Time Non-Invasive Localization for Multiple Lung Nodules [NA]
The document notes the completion of a clinical trial investigating real-time non-invasive localization for multiple lung nodules in non-sma…